ACE and α-adducin polymorphism as markers of individual response to diuretic therapy

Hypertension

Volumn 41, Issue 3 I, 2003, Pages 398-403

  Sciarrone, Maria Teresa ^a   Stella, Paola ^b   Barlassina, Cristina ^b   Manunta, Paolo ^b   Lanzani, Chiara ^b   Bianchi, Giuseppe ^b   Cusi, Daniele ^b  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b NONE

Author keywords

Genetics; Hypertension, essential; Polymorphism; Renin angiotensin system; Sodium

Indexed keywords

ADDUCIN; ALPHA ADDUCIN; DIPEPTIDYL CARBOXYPEPTIDASE; HYDROCHLOROTHIAZIDE; UNCLASSIFIED DRUG;

ACCURACY; ADULT; AGE; ALLELE; ANALYSIS OF VARIANCE; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY MASS; CONTROLLED STUDY; DIURETIC THERAPY; DRUG EFFECT; ESSENTIAL HYPERTENSION; FEMALE; GENDER; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; PREDICTION; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SODIUM ABSORPTION;

ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CALMODULIN-BINDING PROTEINS; DIURETICS; FEMALE; GENETIC MARKERS; GENOTYPE; HUMANS; HYDROCHLOROTHIAZIDE; HYPERTENSION; MALE; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC; SODIUM CHLORIDE SYMPORTER INHIBITORS; TREATMENT OUTCOME;

EID: 0037340242     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.0000057010.27011.2C     Document Type: Article

References (31)

1. Burt VL, Whelton P, Roccella EJ, Brown C, Cutler JA, Higgins M, Horan MJ, Labarthe D. Trends in the prevalence, awareness, treatment, and control of hypertension in the adult US population: data from the Health Examination Surveys, 1960 to 1991. Hypertension. 1995;25:305-313.
2. Colhoun HM, Dong W, Poulter NR. Blood pressure screening, management and control in England: results from the health survey for England 1994. J Hypertens. 1998;16:747-752.
3. Chalmers J. World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension: Guidelines Subcommittee. J Hypertens. 1999;1999:17:151-183.
4. Laragh JH. Vasoconstriction-volume analysis for understanding and treatment of hypertension. Am J Med. 1973;55:261-274.
5. Laragh JH, Lamport B, Sealey J, Alderman MH. Individual response patterns to drugs reveal hypertension mechanisms and simplify treatment. Hypertension. 1988;12:223-226.
6. He FJ, Markandu ND, Mac Gregor GA. Importance of the renin system for determining blood pressure fall with acute salt restriction in hypertensive and normotensive whites. Hypertension. 2001;38:321-325.
7. Hall JE, Guyton AC, Brands MW. Control of sodium excretion and arterial pressure by intrarenal mechanisms and the rennin angiotensin system. In: Laragh JH, Brenner BM, eds. Hypertension: Pathophysiology, Diagnosis and Management. 2nd ed. New York, NY: Raven Press, Ltd; 1995.
8. Cusi D, Barlassina C, Azzani T, Casari G, Citterio L, Devoto M, Glorioso N, Lanzani C, Manunta P, Righetti M, Rivera R, Stella P, Troffa C, Zagato L, Bianchi G. Polymorphisms of alpha-adducin and salt sensitivity in patients with essential hypertension. Lancet. 1997;349:1353-1357.
9. Hiraga H, Oshima T, Watanabe M, Ishida M, Ishida T, Shingu T, Kambe M, Matsuura H, Kajiyama G. Angiotensin I-converting enzyme gene polymorphism and salt sensitivity in essential hypertension. Hypertension. 1996;27:569-572.
10. Giner V, Poch E, Bragulat E, Oriola J, Gonzalez D, Coca A, De La Sierra A. Renin-angiotensin system genetic polymorphisms and salt sensitivity in essential hypertension. Hypertension. 2000;35:512-517.
11. 3-subunit and antihypertensive response to a thiazide diuretic. Hypertension. 2001;37:739-743.
12. Barlassina C, Schork NJ, Manunta P, Citterio L, Sciarrone M, Lanella G, Bianchi G, Cusi D. Synergistic effect of alpha-adducin and ACE genes causes blood pressure changes with body sodium and volume expansion. Kidney Int. 2000;57:1083-1090.
13. Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press. 1989.
14. Lindpainter K, Pfeffer MA, Kreutz R, Stampfer M, Grodstein F, LaMotte F, Buring J, Hennekens CK. A prospective evaluation of an angiotensin-converting-enzyme polymorphism and the risk of ischemic heart disease. N Engl J Med. 1995;332:706-711.
15. Glorioso N, Filigheddu F, Cusi D, Troffa C, Conti M, Natalizio M, Argiolas G, Barlassina C, Bianchi G. α-Adducin 460Trp allele is associated with erythrocyte Na transport rate in North Sardinian primary hypertensives. Hypertension. 2002;39:357-362.
16. Buchner A, Faul F, Erdfelder E. G*Power. A priori, post-hoc, and compromise power analyses for the Macintosh (Version 2.1.2) [Computer program]. Trier, Germany: University of Trier; 1997.
17. Kojima S, Inenaga T, Matsuoka H, Kuramochi M, Omae T, Nara Y, Yamori Y. The association between salt sensitivity of blood pressure and some polymorphic factors. J Hypertens. 1994;12:797-801.
18. Van der Kleij F, de Jong PE, Henning RH, de Zeuuw D, Navis G. Enhanced responses of blood pressure, renal function and aldosterone to angiotensin I in DD genotype are blunted by low sodium intake. J Am Soc Nephrol. 2002;13:1025-1033.
19. Biirmann B, Groschinsky-Grind M. Antihypertensive effect of various doses of hydrochlorothiazide and its relation to the plasma level of the drug. Eur J Clin Pharmacol. 1978;13:195-201.
20. Tiret L, Rigat B, Visvikis S, Breda C, Corvol P, Cambien F, Soubrier F. Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels. Am J Hum Genet. 1992;51:197-205.
21. Danser AH, Schalekamp MA, Bax WA, van den Brink AM, Saxena PR, Riegger GA, Schunkert H. Angiotensin-converting enzyme in the human heart: effect of the deletion/insertion polymorphism. Circulation. 1995; 92:1387-1388.
22. Costerousse O, Allegrini J, Lopez M, Alhenc-gelas F. Angiotensin converting enzyme in human circulating mononuclear cells: genetic polymorphism of expression in T-lymphocytes. Biochem J. 1993;290:33-40.
23. Yoshikawa H, Tanegashima M, Miyagi M, Kobayashi M, Sakai K, Hayashi I, Aikawa A, Ohara T, Hasegawa A. Renal ACE immunohistochemical localization in NIDDM patients with nephropathy. Am J Kidney Dis. 1998;31:301-307.
24. Staessen JA, Wang JG, Ginocchio G, Petrov V, Saavedra AP, Soubrier F, Vlietinck R, Fagard R. The deletion/insertion polymorphism of the angiotensin converting enzyme gene and cardiovascular-renal risk. J Hypertens. 1997;15:1579-1592.
25. Butler R. The DD-ACE genotype and cardiovascular disease. Pharmacogenomics. 2000;1:153-167.
26. Brunner HR. Experimental and clinical evidence that angiotensin II is an independent risk factor for cardiovascular disease. Am J Cardiol. 2001; 87:3C-9C.
27. Swart S, Bing RF, Swales JD, Thurston H. Plasma renin in long-term diuretic treatment of hypertension: effect of discontinuation and restarting therapy. Clin Sci. 1982;63:121-125.
28. Manunta P, Burnier M, D'Amico M, Buzzi L, Maillard M, Barlassina C, Lanella G, Cusi D, Bianchi G. Adducin polymorphism affects renal proximal tubule reabsorption in hypertension. Hypertension. 1999;33: 694-697.
29. Ferrandi M, Salardi S, Tripodi G, Barassi P, Rivera R, Manunta P, Goldshleger R, Ferrari P, Bianchi G, Karlish SJ. Evidence for an interaction between adducin and Na(+)-K(+)-ATPase: relation to genetic hypertension. Am J Physiol. 1999;277(4 pt 2):H1338-1349.
30. Liard JF, Cowley AW Jr, McCaa RE, McCaa CS, Guyton AC. Renin, aldosterone, body fluid volumes, and the baroreceptor reflex in the development and reversal of Goldblatt hypertension in conscious dogs. Circ Res. 1974;34:549-560.
31. Gradual NA, Galloe AM, Garred P. Effects of sodium restriction on blood pressure, renin, aldosterone, catecholamines, cholesterols and triglyceride: a meta-analysis. JAMA. 1998;279:1383-1391.